Trial Profile
STUDY OF PREOPERATIVE AND POSTOPERATIVE IL-2 IMMUNOTHERAPY IN PANCREATIC CANCER SURGERY - RANDOMIZED PHASE 2 STUDY.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2011
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 28 Jul 2011 New trial record